Vycor Medical Inc (VYCO) stock
VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.07+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.24MP/E –Yield –
Vycor Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Vycor Medical's ebitda for the twelve months ending Jun 30, 2026 was $106.84K, up 30.2% year over year. For fiscal 2025 it was $93.42K, up 85.4% from the year before. The highest annual figure on record is $97.69K in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $93.42K | +85.4% |
| FY2024 | Dec 31, 2024 | $50.38K | -48.4% |
| FY2023 | Dec 31, 2023 | $97.69K | – |
| FY2022 | Dec 31, 2022 | -$248.28K | – |
| FY2021 | Dec 31, 2021 | -$369.88K | – |
| FY2020 | Dec 31, 2020 | -$670.87K | – |
| FY2019 | Dec 31, 2019 | -$541.52K | – |
| FY2018 | Dec 31, 2018 | -$1.15M | – |
| FY2017 | Dec 31, 2017 | -$1.04M | – |
| FY2016 | Dec 31, 2016 | -$1.33M | – |
| FY2015 | Dec 31, 2015 | -$1.63M | – |
| FY2014 | Dec 31, 2014 | -$2.36M | – |
| FY2013 | Dec 31, 2013 | -$1.93M | – |
| FY2012 | Dec 31, 2012 | -$2.47M | – |
| FY2011 | Dec 31, 2011 | -$4.42M | – |
| FY2010 | Dec 31, 2010 | -$1.88M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $21.73K | -67.1% |
| Q1 FY2026 | Mar 31, 2026 | $59.79K | +2782.7% |
| Q4 FY2025 | Dec 31, 2025 | -$21.65K | -163.2% |
| Q3 FY2025 | Sep 30, 2025 | $46.97K | – |
| Q2 FY2025 | Jun 30, 2025 | $66.03K | +112.6% |
| Q1 FY2025 | Mar 31, 2025 | $2.07K | -61.2% |
| Q4 FY2024 | Dec 31, 2024 | $34.22K | – |
| Q3 FY2024 | Sep 30, 2024 | -$20.26K | – |
| Q2 FY2024 | Jun 30, 2024 | $31.06K | -72.0% |
| Q1 FY2024 | Mar 31, 2024 | $5.35K | -88.8% |
| Q4 FY2023 | Dec 31, 2023 | -$49.69K | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.10K | – |
| Q2 FY2023 | Jun 30, 2023 | $110.89K | – |
| Q1 FY2023 | Mar 31, 2023 | $47.58K | – |
| Q4 FY2022 | Dec 31, 2022 | -$76.82K | – |
| Q3 FY2022 | Sep 30, 2022 | -$73.49K | – |
| Q2 FY2022 | Jun 30, 2022 | -$59.73K | -245.3% |
| Q1 FY2022 | Mar 31, 2022 | -$38.25K | – |
| Q4 FY2021 | Dec 31, 2021 | -$147.40K | – |
| Q3 FY2021 | Sep 30, 2021 | -$70.67K | – |
| Q2 FY2021 | Jun 30, 2021 | $41.09K | – |
| Q1 FY2021 | Mar 31, 2021 | -$192.90K | – |
| Q4 FY2020 | Dec 31, 2020 | -$162.22K | – |
| Q3 FY2020 | Sep 30, 2020 | -$191.88K | – |
| Q2 FY2020 | Jun 30, 2020 | -$184.72K | – |
| Q1 FY2020 | Mar 31, 2020 | -$132.04K | – |
| Q4 FY2019 | Dec 31, 2019 | -$160.61K | – |
| Q3 FY2019 | Sep 30, 2019 | -$150.45K | – |
| Q2 FY2019 | Jun 30, 2019 | -$115.77K | – |
| Q1 FY2019 | Mar 31, 2019 | -$147.75K | – |
| Q4 FY2018 | Dec 31, 2018 | -$426.75K | – |
| Q3 FY2018 | Sep 30, 2018 | -$89.73K | – |
| Q2 FY2018 | Jun 30, 2018 | -$362.32K | – |
| Q1 FY2018 | Mar 31, 2018 | -$272.55K | – |
| Q4 FY2017 | Dec 31, 2017 | -$299.31K | – |
| Q3 FY2017 | Sep 30, 2017 | -$222.87K | – |
| Q2 FY2017 | Jun 30, 2017 | -$284.63K | – |
| Q1 FY2017 | Mar 31, 2017 | -$230.35K | – |
| Q4 FY2016 | Dec 31, 2016 | -$405.69K | – |
| Q3 FY2016 | Sep 30, 2016 | -$251.43K | – |
See a number that looks wrong?